Search This Blog

Tuesday, March 3, 2026

Select Medical agrees to $16.50 per share take-private

 

 by management-led consortium including Robert A. Ortenzio and WCAS

  • RBC Capital downgraded Select Medical to Sector Perform from Outperform and cut its price target to $16.50
  • RBC cited the company’s agreement to be acquired for $16.50 per share by a management-led consortium as rationale

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.